These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21871511)
1. Combined anti-inflammatory effects of β2-adrenergic agonists and PDE4 inhibitors on astrocytes by upregulation of intracellular cAMP. Christiansen SH; Selige J; Dunkern T; Rassov A; Leist M Neurochem Int; 2011 Nov; 59(6):837-46. PubMed ID: 21871511 [TBL] [Abstract][Full Text] [Related]
2. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats. Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells. Patel BS; Prabhala P; Oliver BG; Ammit AJ Am J Respir Cell Mol Biol; 2015 May; 52(5):634-40. PubMed ID: 25296132 [TBL] [Abstract][Full Text] [Related]
4. Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting β2-adrenoceptor agonist-induced gene expression in human airway epithelial cells. BinMahfouz H; Borthakur B; Yan D; George T; Giembycz MA; Newton R Mol Pharmacol; 2015 Jan; 87(1):64-76. PubMed ID: 25324049 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia. Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681 [TBL] [Abstract][Full Text] [Related]
6. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4. Blease K; Burke-Gaffney A; Hellewell PG Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364 [TBL] [Abstract][Full Text] [Related]
7. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331 [TBL] [Abstract][Full Text] [Related]
8. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat. Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress. Ortiz JL; Milara J; Lluch J; De Diego A; Sanz C; Cortijo J Allergy; 2013 Jan; 68(1):64-73. PubMed ID: 23121078 [TBL] [Abstract][Full Text] [Related]
10. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4. Galindo-Tovar A; Vargas ML; Kaumann AJ Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol. Parkkonen J; Hasala H; Moilanen E; Giembycz MA; Kankaanranta H Pulm Pharmacol Ther; 2008; 21(3):499-506. PubMed ID: 18282775 [TBL] [Abstract][Full Text] [Related]
12. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184 [TBL] [Abstract][Full Text] [Related]
13. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor. Foissier L; Lonchampt M; Cogé F; Canet E J Pharmacol Exp Ther; 1996 Sep; 278(3):1484-90. PubMed ID: 8819536 [TBL] [Abstract][Full Text] [Related]
14. Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle. Duarte T; Menezes-Rodrigues FS; Godinho RO J Pharmacol Exp Ther; 2012 Jun; 341(3):820-8. PubMed ID: 22438472 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Rose RJ; Liu H; Palmer D; Maurice DH Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930 [TBL] [Abstract][Full Text] [Related]
17. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection. Erdogan S; Aslantas O; Celik S; Atik E Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885 [TBL] [Abstract][Full Text] [Related]
18. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605 [TBL] [Abstract][Full Text] [Related]
19. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling. Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492 [TBL] [Abstract][Full Text] [Related]
20. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. McNamee EN; Griffin EW; Ryan KM; Ryan KJ; Heffernan S; Harkin A; Connor TJ Neuropharmacology; 2010; 59(1-2):37-48. PubMed ID: 20361987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]